Sodium Valproate in pharma franchise in Andhra Pradesh

Sodium Valproate in PCD pharma franchise in Bhubaneswar

Sodium Valproate in top pharma company in Solapur

Sodium Valproate in pcd pharma supplier in Patna

Sodium Valproate in phama franchise company in India
Sodium Valproate in phama distributor in Ghaziabad

Home/Products /sodium-valproate-200mg-valproic-acid-87mg-tablet

Valpotime CR 300

Composition : Sodium Valproate 200mg + Valproic Acid 87mg

Dosage Form : Tablet

Packaging Type : Strip Pack

Packaging : 10*10

Price : ₹65/-

Valpotime CR 300 is a controlled-release formulation containing Sodium Valproate (200mg) and Valproic Acid (87mg). It is primarily prescribed for managing epilepsy and bipolar disorder. This combination of active ingredients works synergistically to control seizures and stabilize mood, providing a dual-action treatment for patients with these conditions.

The controlled-release technology in Valpotime CR 300 ensures that the active ingredients are released slowly and consistently into the bloodstream, leading to stable therapeutic effects throughout the day. This helps minimize side effects that may arise from fluctuating drug levels, improving the patient's adherence to the treatment plan and overall quality of life.

Valpotime CR 300 is particularly beneficial for patients suffering from generalized seizures, focal seizures, and manic episodes related to bipolar disorder. It works by regulating the electrical activity in the brain, thus preventing the abnormal neuronal firing responsible for seizures and stabilizing mood in patients with bipolar disorder.

This medication is designed for long-term management and is best suited for patients who require consistent medication throughout the day, making it an effective solution for both epilepsy and bipolar disorder.

Read More

About the Product

Valpotime CR 300 is a controlled-release formulation containing Sodium Valproate (200mg) and Valproic Acid (87mg). It is primarily prescribed for managing epilepsy and bipolar disorder. This combination of active ingredients works synergistically to control seizures and stabilize mood, providing a dual-action treatment for patients with these conditions.

The controlled-release technology in Valpotime CR 300 ensures that the active ingredients are released slowly and consistently into the bloodstream, leading to stable therapeutic effects throughout the day. This helps minimize side effects that may arise from fluctuating drug levels, improving the patient's adherence to the treatment plan and overall quality of life.

Valpotime CR 300 is particularly beneficial for patients suffering from generalized seizures, focal seizures, and manic episodes related to bipolar disorder. It works by regulating the electrical activity in the brain, thus preventing the abnormal neuronal firing responsible for seizures and stabilizing mood in patients with bipolar disorder.

This medication is designed for long-term management and is best suited for patients who require consistent medication throughout the day, making it an effective solution for both epilepsy and bipolar disorder.

Common side effects include nausea, drowsiness, tremors, dizziness, and weight gain. Severe side effects may include liver problems, blood disorders, or pancreatitis. Immediate medical attention should be sought if these occur.

For the treatment of epilepsy (generalized and focal seizures) and the management of bipolar disorder.

Consult your doctor before use if you have liver disease, are pregnant or breastfeeding. Regular blood tests are required during treatment to monitor liver function and blood counts.

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation